Overview

Molecular Triaging of Newly Diagnosed Breast Cancer

Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if using "gene signatures" can be an effective way to decide the best treatment for breast cancer patients. Gene signatures may be able to help researchers predict who will respond to chemotherapy given before surgery.
Phase:
N/A
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Bevacizumab
Cyclophosphamide
Doxorubicin
Epirubicin
Fluorouracil
Liposomal doxorubicin
Paclitaxel